Sumoylation of the P protein at K254 plays an important role in growth of parainfluenza virus 5

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 10261-10268

  Sun, Dengyun ^a,b,c   Xu, Pei ^a,b   He, Biao ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LARGE PROTEIN; PHOSPHOPROTEIN; RNA DIRECTED RNA POLYMERASE; SUMO 1 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS 5; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; RNA SYNTHESIS; SUMOYLATION; VIROGENESIS; VIRUS GENE; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS TITRATION;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; LYSINE; MUTAGENESIS, SITE-DIRECTED; PHOSPHOPROTEINS; RUBULAVIRUS; SUMO-1 PROTEIN; SUMOYLATION; VIRAL PROTEINS; VIRUS REPLICATION;

PARAINFLUENZA VIRUS;

EID: 80053991406     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00389-11     Document Type: Article

References (45)

1. Andreou, A. M., and N. Tavernarakis. 2009. SUMOylation and cell signalling. Biotechnol. J. 4:1740-1752.
2. Bergink, S., and S. Jentsch. 2009. Principles of ubiquitin and SUMO modifications in DNA repair. Nature 458:461-467.
3. Berndt, A., H. Hofmann-Winkler, N. Tavalai, G. Hahn, and T. Stamminger. 2009. Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection. J. Virol. 83:12881-12894.
4. Boggio, R., and S. Chiocca. 2006. Viruses and sumoylation: recent highlights. Curr. Opin. Microbiol. 9:430-436.
5. Buchholz, U. J., S. Finke, and K. K. Conzelmann. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259.
6. Chang, T. H., et al. 2009. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog. 5:e1000493.
7. Fu, J., Y. Xiong, Y. Xu, G. Cheng, and H. Tang. 2011. MDA5 is SUMOylated by PIAS2beta in the upregulation of type I interferon signaling. Mol. Immunol. 48:415-422.
8. Fuentes, S. M., D. Sun, A. P. Schmitt, and B. He. 2010. Phosphorylation of paramyxovirus phosphoprotein and its role in viral gene expression. Future Microbiol. 5:9-13.
9. Geiss-Friedlander, R., and F. Melchior. 2007. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8:947-956.
10. Gilmore, J. M., et al. 2010. Determinants of affinity and activity of the anti-sigma factor AsiA. Biochemistry 49:6143-6154.
11. Girdwood, D., et al. 2003. P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11:1043-1054.
12. Gurer, C., L. Berthoux, and J. Luban. 2005. Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J. Virol. 79:910-917.
13. He, B., et al. 2002. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303:15-32.
14. Hofmann, H., S. Floss, and T. Stamminger. 2000. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J. Virol. 74: 2510-2524.
15. Johnson, E. S. 2004. Protein modification by SUMO. Annu. Rev. Biochem. 73:355-382.
16. Kubota, T., et al. 2008. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J. Biol. Chem. 283:25660-25670.
17. Lamb, R. A., and G. D. Parks. 2007. Paramyxovirudae: the viruses and their replication, p. 1450-1497. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Lippincott, Williams and Wilkins, Philadelphia, PA.
18. Lee, H. R., and J. H. Ahn. 2004. Sumoylation of the major immediate-early IE2 protein of human cytomegalovirus Towne strain is not required for virus growth in cultured human fibroblasts. J. Gen. Virol. 85:2149-2154.
19. Li, S. J., and M. Hochstrasser. 1999. A new protease required for cell-cycle progression in yeast. Nature 398:246-251.
20. Lin, Y., A. C. Bright, T. A. Rothermel, and B. He. 2003. Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J. Virol. 77:3371-3383.
21. Long, J., et al. 2003. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. Proc. Natl. Acad. Sci. U. S. A. 100:9791-9796.
22. Mahajan, R., C. Delphin, T. Guan, L. Gerace, and F. Melchior. 1997. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88:97-107.
23. Marusic, M. B., N. Mencin, M. Licen, L. Banks, and H. S. Grm. 2010. Modification of human papillomavirus minor capsid protein L2 by sumoylation. J. Virol. 84:11585-11589.
24. Matunis, M. J., E. Coutavas, and G. Blobel. 1996. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135:1457-1470.
25. Mi, Z., J. Fu, Y. Xiong, and H. Tang. 2010. SUMOylation of RIG-I positively regulates the type I interferon signaling. Protein Cell 1:275-283.
26. Rangasamy, D., K. Woytek, S. A. Khan, and V. G. Wilson. 2000. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation. J. Biol. Chem. 275:37999-38004.
27. Ren, J., et al. 2009. Systematic study of protein sumoylation: development of a site-specific predictor of SUMOsp 2.0. Proteomics 9:3409-3412.
28. Ross, S., J. L. Best, L. I. Zon, and G. Gill. 2002. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10:831-842.
29. Sapetschnig, A., et al. 2002. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J. 21:5206-5215.
30. Song, L., S. Bhattacharya, A. A. Yunus, C. D. Lima, and C. Schindler. 2006. Stat1 and SUMO modification. Blood 108:3237-3244.
31. Sun, D., P. Luthra, Z. Li, and B. He. 2009. PLK1 down-regulates parainfluenza virus 5 gene expression. PLoS Pathog. 5:e1000525.
32. Sun, D., P. Luthra, P. Xu, H. Yoon, and B. He. 2011. Identification of a phosphorylation site within the P protein important for mRNA transcription and growth of parainfluenza virus. 5. J. Virol. 85:8376-8385.
33. Sun, M., et al. 2004. Conserved cysteine-rich domain of paramyxovirus simian virus 5 V protein plays an important role in blocking apoptosis. J. Virol. 78:5068-5078.
34. Tatham, M. H., et al. 2001. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276:35368-35374.
35. Timani, K. A., et al. 2008. A single amino acid residue change in the P protein of parainfluenza virus 5 elevates viral gene expression. J. Virol. 82:9123-9133.
36. Ungureanu, D., et al. 2003. PIAS proteins promote SUMO-1 conjugation to STAT1. Blood 102:3311-3313.
37. Wilkinson, K. A., and J. M. Henley. 2010. Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 428:133-145.
38. Wilson, V. G., and D. Rangasamy. 2001. Viral interaction with the host cell sumoylation system. Virus Res. 81:17-27.
39. Wu, S. Y., and C. M. Chiang. 2009. Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding. EMBO J. 28:1246-1259.
40. Wu, Y. C., A. F. Deyrieux, and V. G. Wilson. 2007. Papillomaviruses and the host SUMOylation system. Biochem. Soc. Trans. 35:1433-1435.
41. Wu, Y. C., A. A. Roark, X. L. Bian, and V. G. Wilson. 2008. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs). Virology 378:329-338.
42. Xu, K., et al. 2011. Modification of nonstructural protein 1 of influenza A virus by SUMO1. J. Virol. 85:1086-1098.
43. Yamamoto, H., M. Ihara, Y. Matsuura, and A. Kikuchi. 2003. Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J. 22:2047-2059.
44. Yang, S. H., E. Jaffray, R. T. Hay, and A. D. Sharrocks. 2003. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12:63-74.
45. Yueh, A., et al. 2006. Interaction of Moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection. J. Virol. 80:342-352.